Drug intelligence / Profile preview

Onak SR

Development stage: Unknown
Lead developer: Praise Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

**Onak SR** is a topical fixed-dose anti-acne lotion marketed by Praise Pharma for acne, particularly truncal and shoulder acne. It contains **resorcinol 5% w/v** and **precipitated sulfur 5% w/v**. Both ingredients provide keratolytic activity that promotes shedding of superficial skin cells and helps reduce follicular plugging; they also have topical antimicrobial activity relevant to acne-prone skin. ([praisepharma.com](https://www.praisepharma.com/products_onak-sr-lotion.html))

Brand names: Onak SR

Targets

Bacterial 50S ribosomal subunit

Beyond the preview

Go deeper on Onak SR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onak SR.

Explore the full profile